This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on august 2, 2019.Upon further investigation of the reported event, the following information is new and/or changed: g4 (date received by manufacturer).G7 (indication that this is a follow-up report).H2 (follow-up due to additional information).H6 (identification of evaluation codes 4114, 4210, 4307).Method code: 4114 - device not returned.Results code: 4210 - leakage/seal.Conclusions code: 4307 - cause traced to component failurethe sample was not returned.For evaluation; however, a photograph was provided and reviewed.Without the actual sample, a complete investigation could not be performed and a definitive root cause could not be determined.Without the lot number being provided, a retention sample could not be investigated.The most likely root cause of the event is a void in the bond between the tubing and the male connector of the arterial sampling line.A small void in the bond will cause a leak.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|